- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.Prostate CancerSeptember 25, 2020
-
Examination of potential novel biochemical factors in relation to prostate cancer incidence and mortality in UK Biobank.Prostate CancerSeptember 25, 2020
-
Initial Experience with Radical Prostatectomy Following Holmium Laser Enucleation of the Prostate.Prostate CancerSeptember 25, 2020
-
Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment.Prostate CancerSeptember 25, 2020
-
Comparison of diagnostic performance between diffusion kurtosis imaging parameters and mono-exponential ADC for determination of clinically significant cancer in patients with prostate cancer.Prostate CancerSeptember 25, 2020
-
18 F-labeled 1,2,3-triazole-linked Glu-urea-Lys-based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate cance.Prostate CancerSeptember 24, 2020
-
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.Prostate CancerSeptember 24, 2020
-
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging for Initial Staging of Treatment-naïve Intermediate- and High-risk Prostate Cancer: A Retrospective Single-center Study.Prostate CancerSeptember 24, 2020
-
Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer.Prostate CancerSeptember 24, 2020
-
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening.Prostate CancerSeptember 24, 2020
Beyond the Abstracts
-
Racial Disparity in Response to Prostate Cancer Systemic Therapies - Beyond the AbstractProstate CancerSeptember 9, 2020
-
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone - Beyond the AbstractProstate CancerSeptember 8, 2020
-
Test-Retest Repeatability of a Deep Learning Architecture in Detecting and Segmenting Clinically Significant Prostate Cancer on Apparent Diffusion Coefficient (ADC) Maps - Beyond the AbstractProstate CancerSeptember 3, 2020
-
MEIS1 Down-Regulation by MYC Mediates Prostate Cancer Development Through Elevated HOXB13 Expression and AR Activity - Beyond the AbstractProstate CancerAugust 25, 2020
-
Impact of DNA Damage Repair Defects on Response to Radium-223 and Overall Survival in Metastatic Castration-Resistant Prostate Cancer - Beyond the AbstractProstate CancerAugust 17, 2020
-
Ethnic Variation in Prostate Cancer Detection: A Feasibility Study for Use of the Stockholm3 Test in a Multiethnic U.S. Cohort - Beyond the AbstractProstate CancerAugust 17, 2020
-
18F-Fluciclovine Positron Emission Tomography in Men with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiotherapy: Results from LOCATE - Beyond the AbstractProstate CancerAugust 6, 2020
-
Antibody Selection Influences the Detection of AR-V7 in Primary Prostate Cancer - Beyond the AbstractProstate CancerAugust 6, 2020
-
External Evaluation of the Briganti Nomogram to Predict Lymph Node Metastases in Intermediate-Risk Prostate Cancer Patients - Beyond the AbstractProstate CancerAugust 3, 2020
-
A QSP Model of Prostate Cancer Immunotherapy to Identify Effective Combination Therapies - Beyond the AbstractProstate CancerJuly 27, 2020